Creative Life Science Co (ROCO:7837) Long-Term Debt: NT$127 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7837 Creative Life Science Co Ltd ROCO:7837
28 GF Score
Price NT$83.00
! 2 Warning Signs
View Full Analysis

What is Creative Life Science Co Long-Term Debt?

Creative Life Science Co ROCO:7837 28 Long-Term Debt is NT$127 Mil as of Jun. 2026. GuruFocus rates ROCO:7837 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Creative Life Science Co's Long-Term Debt for the quarter that ended in Jun. 2026 was NT$127 Mil.

Creative Life Science Co's quarterly Long-Term Debt increased from Jun. 2025 (NT$120 Mil) to Dec. 2025 (NT$140 Mil) but then declined from Dec. 2025 (NT$140 Mil) to Jun. 2026 (NT$127 Mil).

Creative Life Science Co's annual Long-Term Debt declined from Dec. 2023 (NT$167 Mil) to Dec. 2024 (NT$150 Mil) and declined from Dec. 2024 (NT$150 Mil) to Dec. 2025 (NT$140 Mil).

Creative Life Science Co  (ROCO:7837) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Creative Life Science Co Long-Term Debt Related Terms

Creative Life Science Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Creative Life Science Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creative Life Science Co Long-Term Debt Chart

Creative Life Science Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Long-Term Debt
0.00 167.20 150.22 139.80

Creative Life Science Co Semi-Annual Data
Jun24 Jun25 Dec25 Jun26
Long-Term Debt 158.76 120.17 139.80 127.29
ROCO:7837
28GF Score
Creative Life Science Co Ltd ROCO:7837
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of NT$127 Mil mean?
Creative Life Science Co (ROCO:7837) has a Long-Term Debt of NT$127 Mil as of Jun. 2026.
Is Creative Life Science Co's Long-Term Debt too high?
Creative Life Science Co's current Long-Term Debt is NT$127 Mil. Overall, Creative Life Science Co has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's Long-Term Debt compare to VRTX and REGN?
Creative Life Science Co's Long-Term Debt of NT$127 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Creative Life Science Co's current Long-Term Debt is NT$127 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current Long-Term Debt of NT$127 Mil. The current Long-Term Debt is NT$127 Mil. Creative Life Science Co's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current Long-Term Debt is NT$127 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Creative Life Science Co Business Description

Address Wuquan 3rd Road, No. 24, Wugu District, New Taipei City, TWN, 248021
Creative Life Science Co Ltd is a Taiwanese company that develops and manufactures microbiology products, principally prepared culture media and diagnostic reagents. Its Creative Media Plate (CMP) line includes solid and liquid media supplied in formats such as prepared plated media, prepared tube media, transport medium, viral transport medium (VTM and inactivated VTM), bacterial strain preservation systems, and SteriPack triple-wrapped media. These products are used in clinical microbiology laboratories, basic microbial research, environmental monitoring, biosafety testing, and quality control applications. The company serves hospitals, diagnostic laboratories, research institutions, and industrial customers that require ready-to-use microbiological media. Revenue is generated mainly through the sale of these consumable media products and related reagents, with distribution in Taiwan and export markets. The company also produces diagnostic reagents that complement its media portfolio.
28GF Score

Get the complete analysis for ROCO:7837

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$83.00
Price